Combination Osteogenic Therapy in Established Osteoporosis

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

November 30, 1998

Study Completion Date

October 31, 2003

Conditions

Osteoporosis, Post-Menopausal

Interventions

DRUG

PTH 1-34

DRUG

MFPSR-fluoride

Trial Locations (1)

Jerry L. Pettis Memorial Veterans Medical Center, Loma Linda

All Listed Sponsors

lead

US Department of Veterans Affairs

FED

NCT00018447 - Combination Osteogenic Therapy in Established Osteoporosis | Biotech Hunter | Biotech Hunter